NEW YORK, April 08, 2016 -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Brixmor Property Group Inc. (“Brixmor” or the “Company”) (NYSE:BRX) of the May 31, 2016 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.
The lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased Brixmor securities between October 27, 2014 and February 5, 2016 (the “Class Period”). The case, Westchester Putnam Counties Heavy & Highway Laborers Local 60 Benefit Funds v. Brixmor Property Group Inc., et al., No. 1:16-cv-02400 was filed on March 31, 2016, and has been assigned to Judge Analisa Nadine Torres.
The lawsuit focuses on whether Brixmor and its executives violated federal securities laws by allegedly making false and/or misleading statements and/or failing to disclose that: (1) the Company and its senior executives manipulated income items for nine quarters to achieve consistent quarterly same property net operating income (“NOI”) growth; (2) the Company lacked adequate internal and financial controls; and (3) that, as a result, statements about Brixmor’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis.
Specifically, the lawsuit alleges that on February 8, 2016, Brixmor disclosed that the Company and certain high level executives had engaged in a scheme whereby they were “smoothing” the Company’s NOI numbers to achieve consistent quarterly same property NOI growth.
On this news, share price fell $5.32 per share on unusually heavy trading volume to close at $21.10 per share, a 20.1% drop, on February 8, 2016.
Request more information now by clicking here: www.faruqilaw.com/BRX. There is no cost or obligation to you.
Take Action
If you invested in Brixmor common stock, bonds or options between October 27, 2014 and February 5, 2016 and would like to discuss your legal rights, visit www.faruqilaw.com/BRX. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected]. Faruqi & Faruqi, LLP also encourages anyone with information regarding Brixmor’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class that is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP 685 Third Avenue, 26th Floor New York, NY 10017 Attn: Richard Gonnello, Esq. [email protected] Telephone: (877) 247-4292 or (212) 983-9330


Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Italy Fines Apple €98.6 Million Over App Store Dominance
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 



